Abbott Laboratories buy Daiwa Capital Markets
Start price
21.10.25
/
50%
€110.72
Target price
21.10.26
€116.80
Performance (%)
-17.45%
Price
20.03.26
€91.40
Summary
This prediction is currently active. The prediction for Abbott Laboratories disappoints with a performance of -17.45%. This prediction currently runs until 21.10.26. The prediction end date can be changed by Daiwa_Capital_Market at any time. Daiwa_Capital_Market has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -3.413% | -3.413% |
| iShares Core DAX® | -4.932% | -11.977% |
| iShares Nasdaq 100 | -2.634% | -2.218% |
| iShares Nikkei 225® | -4.733% | -10.900% |
| iShares S&P 500 | -2.544% | -3.540% |
Comments by Daiwa_Capital_Market for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE:ABT) had its price target raised by analysts at Daiwa Capital Markets from $134.00 to $136.00. They now have an "outperform" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Daiwa_Capital_Market for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€92.30
31.01.26
31.01.26
€95.29
31.01.27
31.01.27
-0.98%
20.03.26
20.03.26
